Posts by month
October 2020
11 posts
Combined therapies offer the key to drug-resistant cancer
ed the combination of the PARP inhibitor olaparib, and the AKT inhibitor capivasertib, and showed this combination was well tolerated…
Input your search keywords and press Enter.